Regencell Bioscience Holdings Limited (RGC) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Regencell Bioscience Holdings Limited, updated every trading day.
Health Care · Medicinal Chemicals and Botanical Products
Price
$7.27
−2.55% today
Market cap
$3.7B
Overall quality
—
Kronos AI 30-day
+5.6%
5 of 8 simulated paths end higher
Regencell Bioscience Holdings Limited (RGC) is a Health Care company in Medicinal Chemicals and Botanical Products, worth $3.7B. It trades at $7.27, down 2.55% today. Kronos AI's 30-day forecast is +5.6% (5 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $7.87 (+5.6%) |
| Likely range | −9.7% … +60.8% |
| As of | 2026-10-27 |
5 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Medicinal Chemicals and Botanical Products
- PM — Philip Morris International Inc
- BTI — British American Tobacco Industries p.l.c.
- MO — Altria Group Inc.
- DFTX — Definium Therapeutics Inc. Common Shares
- TRLV — Trulieve Cannabis Corp. Subordinate Voting Shares
- RLX — RLX Technology Inc. American Depositary Shares each representing the right to receive one (1)
For information only, not investment advice. Prices updated: 2026-10-29.